Glaxo CT1341 is a new steroid anaesthetic. It produces immediate induction of anaesthesia of short duration when injected intravenously into experimental animals and recovery is rapid and uncomplicated. It has a high therapeutic index and has proved compatible with the adjuvant and pre-anaesthetic drugs, inhalational anaesthetics and neuromuscular blocking drugs commonly employed in anaesthesia. It is free from vascular irritation effects even when administered intra-arterially.
We describe here some results of animal expenmenu with a new steroidal anaesthetic agentGlaxo CT1341-«f high therapeutic index which appears to have the advantageVof hydroxydione andthe barbiturates but not their demerits.
MATERIALS

Glaxo CT1341 injection.
The injection is formulated as follows: .^ m ^ ^.^ do f ^^^ î s similar. The activity of a mixture containing 3a-hvdroxv-5a-preEnane-11^0-dione and its 21-acetoxy denvative was consistent with simple addition of their respective activities. The presence of ±& 21-acetoxy compound however, greatly mcreases ,^L j°l ublhty °f 3 T^Tr pregnane-ll^O-<hone in Cremophor EL (polyf^/fted castor ou-Badische Andm und Soda-Fabrik A.G., obtamed from Viaor Blagden C°-> Limited).
DOSAGE
Glaxo CT1341 contains 12 mg total steroid/ml. Dosage may be expressed as either ml formulated -solution/kg bodyweight or mg steroid/kg body weight. Although the two steroids possess different potencies the latter method of expression is generally preferred because the solution may sometimes be diluted with saline before use.
METHOD AND RESULTS
Anaesthetic activity of CT1341. CT1341 was diluted with physiological saline for intravenous injection to mice and rats and was administered undiluted to rabbits, cats, dogs and monkeys. Injections were made into the tail veins of mice and rats, the marginal ear veins of rabbits, the femoral vein of monkeys and the cephalic vein in cats and dogs at a rate equivalent to 0.1 ml undiluted CT1341/kg/sec. The time between injection and the loss of "righting reflex" was recorded as the induction Hnv and the duration of loss of the reflex as the sleeping time. Mice and rats were maintained at a controlled environmental temperature of 35 °C during the period of sleep. The results are given in table I. CT1341 possessed similar anaesthetic potency in the rabbit, cat, monkey and dog but was less potent in the mouse and the rat. It was more active on a dose to body weight basis than other presently used induction anaesthetics and it produced immediate loss of consciousness at the lowest active doses in all species examined. Recovery from the effects of non-lethal doses was rapid and uncomplicated in all species except the dog where the recovery pattern was complicated by the pharmacological effects of the vehicle (see later).
The dose required to produce loss of the "righting reflex" in 50 per cent of mice and the dose required to kill 50 per cent of mice-the anaesthetic dose 50 (AD50) or lethal dose 50 (LD50)-was determined for CT1341 and some other anaesthetics (table II) .
No cumulative effects were seen in mice on repeated intravenous injection of CT1341 when successive equal doses of the anaesthetic were administered 30 sec after the animals regained their righting reflex. Cumulation of effect was very apparent widi thiopentone sodium but much less so with methohexitone sodium (table HI) . The lack of cumulative effect of CT1341 demonstrated here and later when CT1341 was infused intravenously in cats is consistent with preliminary results which indicate that elimination of the anaesthetic from the blood stream of mice occurs rapidly ( fig. 1 ). Studies on the distribution and metabolism of CT1341 using C 14 -labelled material are in progress and it is hoped to publish the results elsewhere.
Vascular irritancy and vomiting.
No vein damage has been encountered in any animal irrespective of dosage and no vomiting has been seen in monkeys or cats. Deliberate intraarterial injection of CT1341 into the central artery of the rabbit ear during occlusion of the marginal ear veins (a modification of the method of Kinmonth and Shepherd, 1959) produced no macroscopic arterial damage, whereas similar injections of thiopentone sodium (5 per cent) produced oedema and necrosis ( fig. 2 ). The rabbits were killed 4 days after the intra-arterial injections and their right ears removed and preserved in buffered formalin The histological changes seen after intra-arterial thiopentone sodium (5 per cent) were severe; in all animals the central area of the ear was necrotic and contained large quantities of extravasated blood. The surrounding healthy areas were demarcated by a zone of fibroblastic reaction and early epithelial regeneration beneath the necrotic epidermis. Thiopentone sodium (2.5 per cent) produced less severe damage which gradually resolved on successive days. No necrotic areas were seen in the ears of rabbits which received CT1341 and histologically there was no congestion, haemorrhage, oedema or arterial damage. The only consistent finding in CT1341-treated animals was a sparse round cell infiltration along the marginal ear veins; this possibly resulted from the mechanical occlusion of these vessels for 15 tnin after intra-arterial injection of the anaesthetic.
The effects of CT1341, thiopentone sodium and propanidid in conscious cats. The cat rather than the dog has been used for the investigation of the major pharmacological actions of CT1341. The dog and certain other members of the genus Canis exhibit an "allergic" response to polyoxyethylene derivatives of hexitol anhydride partial fatty acid esters such as Tween 20, 40, 60 and 80 (Krantz et al., 1948 (Krantz et al., , 1949 . Krantz and his colleagues showed that intravenous injection in the dog of as little as 0.5 ml/kg of 5.0 per cent Tween 20 solution produced a prolonged fall in blood pressure, and that as little as 0.1 ml of a 1:200 dilution of Tween 20 in physiological saline produced a positive weal response when injected intradermally on the abdomen. These effects, and other manifestations of an allergic type such as urticaria and erythema, were believed to be the result of the release of histamine or histamine-like substances. Cremophor EL, a non-ionic polyoxyethylated emulsifying agent employed in tie formulation of both CT1341 and the anaesthetic agent propanidid (Horatz, Frey and Zindler, 1965) , elicits similar effects in dogs which would have obscured the general pharmacodynamic effects of CT1341 and any interactions between CT1341 and other drugs used in general anaesthesia.
Adult cats of either sex were employed in these experiments without any pre-anaesthetic medication. They had previously had polyvinyl cannulae implanted in the right external jugular vein and descending aorta under halothane/nitrous oxide anaesthesia a minimum of 4 days before the first experiment. The arterial cannula was inserted in the right common carotid artery and guided over the aortic arch into the descending aorta with the tip at the level of the heart; the venous cannula was inserted in the right external jugular vein and guided so that the tip lay in the region of the junction with the superior vena cava. The cannulae were led subcutaneously to the interscapular region of the neck and exteriorized there. About 5-10 cm of cannula was left outside the neck for connection to the injection or recording instruments. The cannulae were filled with sterile heparin solution (5,000 i.u./ml) and closed when not in use by crimped stainless steel needles. Cats prepared in this way tolerated the implants well for a number of weeks, with few untoward sequelae. The cannulae were flushed with sterile heparin solution every 48 hours to maintain patency.
Aortic blood pressure recording and intravenous drug injections were performed with the cat able to move freely within a glass-walled cage situated in a quiet room at an ambient temperature of 23-27°C to which they had been accus- The tests were performed by a modification of the method described by Kinmonth and Shepherd (1959). tomed during "training" sessions. The cannulae were fixed to a collar around the cat's neck and connected to the recording instruments in such a way that the cat had unrestricted movement.
Blood pressure was monitored using a Bell and Howell transducer, and heart rate (derived from the blood pressure pulse) was monitored using a Devices instantaneous rate meter.
Intravenous drug injections were made at a rate of approximately 0.05 ml/kg/sec using either CT1341, a freshly prepared solution of thiopentone sodium (Intraval 2.5 per cent) or propanidid (Epontol 5 per cent) and flushed in with 1.5 ml heparinized saline. Injection of saline (1.5 ml) failed to elicit any behavioural response in the conscious cat and was almost without effect on blood pressure or heart rate. The smaller dose of each anaesthetic employed in these experiments was the approximate minimum amount required to produce loss of righting reflex in cats. The larger dose was the maximum tolerated in spontaneously respiring cats. It was determined in preliminary experiments by giving a series of injections at 2-3-day intervals starring with the minimum anaesthetic dose, each subsequent dose being twice the previous dose. Doubling the mavimiim tolerated dose was invariably lethal.
CT1341, thiopentone sodium and propanidid produced loss of righting reflex within 10-30 seconds from the commencement of injection and a variable, dose-dependent period of anaesthesia followed by recovery. Cardiovascular effects have been divided into those which occurred in the first 11 minutes and those appearing lf-5 minutes after injection. The maximum responses of the mean aortic blood pressure, heart rate, and effects on respiration during these periods are summarized in table IV. CT1341 1.2 mg/kg produced transient falls in blood pressure and tachycardia 20-30 sec after injection. These changes were succeeded by small pressor effects during emergence from anaesthesia. The cats were able to stand 6-9 min after injection and after a period of ataxia rapidly returned FIG. 2 (continued) Under light anaesthesia (produced by intravenous injection of pintobarbitone sodium into the marginal vein of the left ear) 0.5 ml anaesthetic was injected into the central artery of the right ear towards the periphery during occlusion of the marginal veins. The central artery was occluded immediately after injection and the vessels were kept clamped for 15 min. to normal. Thiopentone sodium 3 mg/kg was associated with variable effects on blood pressure, but the tachycardia and the recovery from anaesthesia were similar to those seen with CT1341. Propanidid 8 mg/kg produced a sharp transient fall in blood pressure and tachycardia followed by marked pressor effects during recovery of the righting reflex. Recovery was very rapid and uncomplicated in two cats but the third salivated profusely 20 min after injection for a period of 25 min.
The maximum dose of CT1341 employed in these studies was 19.2 mg/kg confirming the wide safety margin obtained in mice. Respiration was never arrested after CT1341 whereas apnoea occurred in all three cats given thiopentone sodium 24 mg/kg. Hyperventilation, gasping and tachypnoea were observed in the three cats injected with propanidid 32 mg/kg.
The maximum doses of CT1341, thiopentone and propanidid produced marked changes in mean aortic blood pressure and heart rate during the first 5-min period after injection (table TV) . After recovery from the initial effects of injection CT1341-treated cats exhibited a prolonged hypotensive response during deep anaesthesia (mean aortic blood pressure 70 mm Hg (-29 per cent) in cat 1269, 70 mm Hg (-22 per cent) in cat 1245 and 35 mm Hg (-67 per cent) in cat 1239). Similarly thiopentone produced a prolonged fall in blood pressure during the period of surgical anaesthesia. The effects observed with propanidid were quantitatively and qualitatively different from those seen after the mavimiinri doses of CT1341 and thiopentone. Emergence from anaesthesia after propanidid 32 mg/kg was very rapid but the corneal and flexor withdrawal reflexes were never obtunded (except momentarily in one cat).
The effects of pre-and postoperative medicaments
on the activity of CT1341. Fasted cats received 1.2 or 7.2 mg/kg CT1341 into the cephalic vein 1 hour after treatment with a pre-or postoperative adjuvant drug. The cats were re-used at intervals of not less that one week. The adjuvants were administered either orally in gelatine capsules as powder or liquid, or by intramuscular injection into the gluteal muscle of the right hind limb.
Although large doses of adjuvant medications were employed (table V) very few differences were observed in the responses of the cats to CT1341. Pretreatment of cats with atropine and pethidine or with papaveretum and hyoscine-Nbutylbromide increased the time to recovery of reflexes such as the corneal but not the time_to complete recovery from the anaesthetic. Quinalbarbitone, which itself rendered the cats ataxic, prolonged the period for complete recovery from the anaesthetic. No other adverse reactions were observed during the course of the experiment and the cats remained in good health, eating and sleeping normally throughout, despite receiving fourteen periods of CT1341 anaesthesia in fourteen weeks.
The effects of induction with CT1341 on sub-
sequent maintenance of anaesthesia with inhalational anaesthetics. Fasted adult cats without pre-anaesthetic medication were used in these experiments. All the cats were used on more than one occasion but never at intervals of less than one week. Anaesthesia was induced with CT1341 (7.2 mg/kg) and oral endotracheal intubation performed with but litde resistance using a 5-mm cuffed endotracheal tube. A pneumotachograph screen was interposed in the airway and the inspiratory half-cycles were integrated over 1-min periods using a Devices integrator giving a record of respiratory minute volume in l./min. Needle electrodes were inserted in the skin of the limbs and e.c.g. recordings were made; heart rate was derived from the RR interval of the lead II e.c.g. using a Devices instantaneous rate meter. All information was recorded on magnetic tape on an Ampex SP-300 and displayed on a Devices M8 recorder. Five to ten minutes after induction with CT1341, when the setting-up procedures described above were complete, the endotracheal tube was connected to a Boyle anaesthetic machine and anaesthesia was maintained for a further 50 min with either halothane, methoxyfturane, chloroform, trichloroethylene, diethyl ether or cyclopropane. Each inhalational anaesthetic was tested in three cat experiments, nitrous oxide (75-80 per cent) and oxygen (25-20 per cent) being used as carrier gas (total flow rate 2 l./min) in all experiments except where cyclopropane was administered when oxygen alone was used. The concentration of anaesthetic vapour or gas was adjusted to maintain adequate depth of anaesthesia; cats breathed spontaneously throughout the experiment. After 50 min exposure to the inhalational agent the cats were allowed to recover consciousness breathing air. Several of the inhalational agents used are known to be poor anaesthetics in cats, particularly when premedication has been omitted, and some respiratory depression, cardiac arrhythmia and increases in oral and bronchial secretions occurred in several experiments when these agents were used. The results are summarized in table VI. The responses of the cats during maintenance with inhalational agents and the pattern of their subsequent recovery from the 1-hour period of anaesthesia reflected the pharmacological properties of the inhalational agents employed. All cats survived the maintenance period and recovered satisfactorily; there was no evidence that CT1341 affected the responses of the cats to the inhalational anaesthetics in any way.
CT1341 and neuromuscular blocking drugs.
Six adult fasted cats were each used twice with an interval of one week between experiments. The animals were premedicated intramuscularly with atropine sulphate (1 mg base/kg) and pethidine hydrochloride (7.5 mg/kg) 1 hour before induction with CT1341 (7.2 mg/kg). Suxamethonium chloride, gallamine triethiodide or tubocurarine chloride was mixed in the syringe with the CT1341 and injected intravenously. Endotracheal intubation was performed and maintenance with 1 per cent halothane (carried in 80 per cent nitrous oxide, 20 per cent oxygen) was instituted immediately and respiratory and heart parameters measured as described previously. Two of the cats which received suxamethonium with the induction anaesthetic also received either gallamine or tubocurarine 10 min after induction. When artificial respiration was applied the anaesthetic gases were administered through a Palmer respiration pump. Cats were normally exposed to halothane for 30 min and then to nitrous oxideoxygen alone until spontaneous respiration occurred; halothane was administered for a longer period as required when tubocurarine was injected because of the longer duration of neuromuscular blockade. The drugs and dosages used are recorded in table VII. Endotracheal intubation was accomplished more easily in those cats which had received premedication and administration of a neuromuscular blocking drug than in the cats used in the previous experiments. All the cats survived the treatment and recovered satisfactorily. The neuromuscular blockade produced by suxamethonium was typically of the short duration depolarization type and the effects wore off during the maintenance period with halothane.
Gallamine and tubocurarine produced characteristic non-depolarization block of longer duration. Block produced by high dosages of these two compounds was satisfactorily antagonized with intravenous administration of neostigmine bromide (50 /*g/kg).
Infusion of CT1341.
Anaesthesia was induced in five fasted adult cats with CT1341 (7.2 mg/kg) injected intravenously in the cephalic vein followed immediately by infusion of CT1341 (0.24 mg/kg/min). Respiratory and heart parameters were measured as described previously and rectal temperatures were measured in addition. One cat survived 2 hours of CT1341 infusion and another cat survived 4 hours infusion. Of the other three cats, all of which were intended to receive 6-hour infusions two survived and one died after 5 hours 44 min. The recovery of the first two cats (2 hours and 4 hours infusion periods) was rapid and complete on cessation of the intravenous infusion but the two cats which survived 6-hour infusions exhibited a slower recovery. Rectal temperatures remained in the normal range both during anaesthesia and in the 24-hour postanaesthetic period.
In the cat which died the respiration became progressively embarrassed after 5£ hours of infusion (total dose 88.8 mg/kg). Respiratory rate and minute volume decreased and S-T depression appeared in the electrocardiogram. When respiration failed death ensued despite artificial respiration and external cardiac massage.
Pyrexia.
Pyrexia has been reported following the intramuscular injection of 3a-hydroxy-5j3-pregnane-11,20-dione in man (Kappas et al., 1960) but no pyrexia was observed in cats after infusion with CT1341 for 6 hours. In further experiments in cats intramuscular or intravenous injection of CT1341 failed to produce pyrexia although a modest pyrexia was observed in these cats after intramuscular or intravenous injection of 3a-hydroxy-5/3-pregnane-ll,20-dione. The failure to demonstrate pyrexia in cats after CT1341 is consistent with findings in man which indicated that of four isomeric 17-ketosteroids only those with a 5/3-configuration provoked fever (Kappas et al., 1957) .
Endocrinologiccd effects of CT1341.
CT1341 has been investigated for possible hormonal effects in the mouse, rat and rabbit. It caused a significant reduction in the thymus weight (method of Child et al., 1968) betamethasone calculated on a weight basis and thus is slightly less active than hydrocortisone. CT1341 did not affect urinary electrolyte excretion, however, when administered intravenously or subcutaneously to adrenalectomized rats and showed no evidence of mineralocorticoid activity.
CT1341 was without significant effect on the endometrium of oestrogen-primed does when tested by the method of McPhail (1934) and was similarly devoid of activity on the uterus of weanling female mice, indicating lack of oestrogenic or progestational activity. Injected intravenously in mice CT1341 antagonized the uterotropic effects of injected oestradiol and it therefore possessed weak anti-oestrogenic activity.
DISCUSSION
Glaxo CT1341, a new anaesthetic agent, is a mixture of 3crhydroxy-5a-pregnane-ll,20-dione and 21-acetoxy-3a-hydroxy-5a-pregnane-11^0-dione dissolved in 20 per cent aqueous Cremophor EL. Although the steroidal components of CT1341 are only poorly water-soluble a stable, non-viscous aqueous solution has been achieved with 20 per cent aqueous Cremophor EL as the vehicle. The solution can be diluted with physiological saline if required.
CT1341, at the lowest active doses, produces immediate loss of consciousness in all animal species examined. While investigated primarily as an induction agent, surgery has been performed with CT1341 alone when higher dosages have been administered. Recovery from anaesthesia is rapid and uncomplicated; no vomiting or vein damage has been encountered in any animal, and when CT1341 was deliberately injected intra-arterially in rabbits it produced none of the serious complications which followed the intra-arterial injection of thiopentone.
The results summarized in this report are from experiments designed to simulate the conditions under which an agent such as CT1341 might be used in anaesthetic practice. However, a series of non-recovery experiments in cats has also been carried out in which CT1341, general anaesthetics and anaesthetic-adjuvant drugs have been administered in very high dosages, such that pharmacodynamic actions and interactions would be expected to be exaggerated. Dose-related respiratory and cardiovascular effects were seen with CT1341 which were transient with doses up to 10.8 mg/kg. The highest doses given (32.4 mg/kg) produced apnoea, cardiovascular collapse and death. When CT1341 was infused intravenously respiratory and cardiovascular depression were only experienced at high rates of infusion well in excess of those required to produce deep surgical anaesthesia. With the very high infusion rates the responses to injected acetylcholine and stimulation of the autonomic nervous system were unaffected, but there was some reduction in the responses to injected catecholamines with partial recovery when the rate of infusion of CT1341 was reduced. It is intended to submit these results, and a fuller account of the experiments in conscious cats with implanted cannulae, for publication elsewhere.
Recovery from anaesthesia was rapid and uncomplicated in cats which received single intravenous injections of CT1341 but it was more prolonged in cats which had been maintained in a state of deep anaesthesia for periods of up to 6 hours with intravenous infusions of CT1341, at a rate of 0.24 mg/kg/min. The death of one cat during prolonged infusion of CT1341 and the lassitude exhibited by others during the recovery period may have been reflections of the effects of the large infused load of vehicle rather than effects of the administered steroids.
Neuromuscular transmission was normal in cats anaesthetized for long periods with infused doses of CT1341. The responses to neuromuscular blocking agents and their antagonists were similar to those seen with other anaesthetics.
Induction of anaesthesia with CT1341 and subsequent recovery were not adversely affected by treatment of cats with a number of drugs commonly used in pre-anaesthetic and postoperative medication. Experiments in which anaesthesia was induced with CT1341 and maintained with inhalational anaesthetics, in some of which neuromuscular blockers were administered, indicate that CT1341 may be expected to fit safely into a sequence of balanced anaesthesia.
